Immunogenicity of a Live Dengue Vaccine (TAK-003)

被引：4
|
作者：
de Silva, Aravinda [1 ]
White, Laura [1 ]
机构：
[1] Univ N Carolina, Sch Med, Dept Microbiol & Immunol, Chapel Hill, NC USA
来源：
JOURNAL OF INFECTIOUS DISEASES | 2022年 / 227卷 / 01期
关键词：
D O I：
10.1093/infdis/jiac424
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：163 / 164
页数：2
相关论文
共 50 条
  • [1] Immunogenicity, Safety and Efficacy of the Dengue Vaccine TAK-003: A Meta-Analysis
    Flacco, Maria Elena
    Bianconi, Alessandro
    Cioni, Giovanni
    Fiore, Matteo
    Calo, Giovanna Letizia
    Imperiali, Gianmarco
    Orazi, Vittorio
    Tiseo, Marco
    Troia, Anastasia
    Rosso, Annalisa
    Manzoli, Lamberto
    VACCINES, 2024, 12 (07)
  • [2] Bridging the immunogenicity of a tetravalent dengue vaccine (TAK-003) from children and adolescents to adults
    LeFevre, Inge
    Bravo, Lulu
    Folschweiller, Nicolas
    Medina, Eduardo Lopez
    Moreira, Edson Duarte
    Nordio, Francesco
    Sharma, Mayuri
    Tharenos, Leslie M.
    Tricou, Vianney
    Watanaveeradej, Veerachai
    Winkle, Peter J.
    Biswal, Shibadas
    NPJ VACCINES, 2023, 8 (01)
  • [3] Bridging the immunogenicity of a tetravalent dengue vaccine (TAK-003) from children and adolescents to adults
    Inge LeFevre
    Lulu Bravo
    Nicolas Folschweiller
    Eduardo Lopez Medina
    Edson Duarte Moreira
    Francesco Nordio
    Mayuri Sharma
    Leslie M. Tharenos
    Vianney Tricou
    Veerachai Watanaveeradej
    Peter J. Winkle
    Shibadas Biswal
    npj Vaccines, 8
  • [4] BRIDGING THE IMMUNOGENICITY OF A TETRAVALENT DENGUE VACCINE CANDIDATE (TAK-003) FROM CHILDREN AND ADOLESCENTS TO ADULTS
    Halim, C.
    Tricou, V.
    Nordio, F.
    Folschweiller, N.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2023, 130 : S10 - S10
  • [5] COST-EFFECTIVENESS OF THE DENGUE VACCINE TAK-003 IN THAILAND
    Shen, J.
    Kharitonova, E.
    Biswal, S.
    Sharma, M.
    Aballea, S.
    Tytula, A.
    Zawieja, J.
    Towle, P.
    Hanley, R.
    Rungmaitree, S.
    VALUE IN HEALTH, 2023, 26 (06) : S162 - S162
  • [6] Effect of the Tetravalent Dengue Vaccine TAK-003 on Sequential Episodes of Symptomatic Dengue
    Saez-Llorens, Xavier
    Biswal, Shibadas
    Borja-Tabora, Charissa
    Fernando, LakKumar
    Liu, Mengya
    Wallace, Derek
    Folschweiller, Nicolas
    Reynales, Humberto
    LeFevre, Inge
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2023, 108 (04): : 722 - 726
  • [7] Effectiveness and safety of the tetravalent TAK-003 dengue vaccine: a systematic review
    Bengolea, Agustin
    Scigliano, Clara
    Ramos-Rojas, Jose T.
    Rada, Gabriel
    Catalano, Hugo N.
    Izcovich, Ariel
    MEDICINA-BUENOS AIRES, 2024, 84 (04) : 689 - 707
  • [8] Clinical Safety Experience of TAK-003 for Dengue Fever: A New Tetravalent Live Attenuated Vaccine Candidate
    Patel, Sanjay S.
    Rauscher, Martina
    Kudela, Maria
    Pang, Hang
    CLINICAL INFECTIOUS DISEASES, 2023, 76 (03) : E1350 - E1359
  • [9] Pregnancy outcomes following unintentional exposure to TAK-003, a live-attenuated tetravalent dengue vaccine
    Rauscher, Martina
    Youard, Zeb
    Faccin, Alice
    Patel, Sanjay S.
    Pang, Hang
    Zent, Olaf
    EXPERT REVIEW OF VACCINES, 2025, 24 (01) : 221 - 229
  • [10] COST-EFFECTIVENESS ANALYSIS OF THE TAK-003 DENGUE VACCINE INTRODUCTION IN ARGENTINA
    Uruena, A.
    Giglio, N.
    Micone, P., V
    Rapaport, S.
    Towle, P.
    Shih, D.
    Langer, J.
    Carbone, A.
    VALUE IN HEALTH, 2024, 27 (12)
12345